Inflammatory and neurodegenerative pathological features lead to cognitive impairment in 50–70% of multiple sclerosis patients. Biomarkers of axonal damage in multiple sclerosis include macular ganglion cell layer and retinal nerve fiber
Maximize the informational quality of your email inbox by selectively subscribing to evidence-based health and wellness resources that are informed by rigorous scientific research and medical expertise.
Your privacy is important to us
© 2020-2022 HealthSciaxis a Sciaxis Company. All rights reserved. Our website services, content, and products are for informational purposes only. HealthSciaxis does not provide medical advice, diagnosis, or treatment. See additional information.
